Clinical Trial Update: Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Acthar Gel in chronic pulmonary sarcoidosis; trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis
• Sarcoidosis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: University of Cincinnati | Conditions: Sarcoidosis, Pulmonary Sarcoidosis | Phase 4 | Status: UNKNOWN